Navigation Links
Innovative BioDefense Introduces Zylast Antiseptic Lotion
Date:7/30/2013

LAKE FOREST, Calif., July 30, 2013 /PRNewswire/ -- Innovative BioDefense Inc., the developer of a full product line of Zylast™ antiseptic products for use in healthcare, nursing, food preparation, schools, cruise ships, and homes, introduces Zylast Lotion, available in 2 & 8 oz bottles, or in ADA-approved, wall-mounted dispensers.  Zylast Lotion is protected by patents and other intellectual property and can be viewed at http://bit.ly/12nLtjt

In clinical and laboratory studies, Zylast Lotion has been demonstrated to kill very rapidly a wide spectrum of germs, including E. Coli (99.9999%), S. Aureus (99.9997%), K. Pneumoniae (99.9999%), and S. Pyogenes (99.9999%), while being persistent for six hours after application.  The active ingredient is benzethonium chloride (BZT, 0.2%), together with a proprietary blend of adjuvants that enhance the persistence and rapid kill.  Innovative BioDefense has posted Time-Kill and Persistence papers on its website at www.zylast.com with information on the study results.

Clinical studies have shown that use of Zylast Lotion reduces illness absenteeism in schools by 41.6% among students and 24.7% among teachers and staff.  The Lotion is all-natural, water-based, and Triclosan-free.

"First, the Zylast products are persistent for six hours, so children are protected beyond the 15-second lifespan of an alcohol sanitizer.  Second, the Zylast Lotion is effective against pathogens like the Norovirus, rotavirus, and the common cold – some of the most prevalent diseases among children, and germs against which alcohol sanitizers are relatively ineffective.  Finally, the product is water-based and moisturizes the hands, so children and staff actually like using it, which greatly improves compliance." – Dr. Beth McNichol


'/>"/>

SOURCE Innovative BioDefense Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Innovative Cancer Treatment Supported by NICE
2. Innovative Krebsbehandlung wird von NICE unterstützt
3. UBM Canon and MD+DI Proudly Announce 27 Innovative Products as Winners of the 2013 Medical Design Excellence Awards
4. Andrews Institute offers innovative technology for spine surgery
5. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
6. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
7. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
8. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
9. BlueBin Inc. Launches to Deliver Innovative Overhaul for Ailing Healthcare Supply Chain
10. VUCA Health Announces Rapid Adoption of its MedsOnCue Digital Patient Engagement Solution Supporting Health Literacy by Innovative Pharmacies across 19 States
11. TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of targeted antiviral therapies, announced ... Annual ROTH Conference, to be held March 8-11, ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, announced today that ... top rehabilitation hospitals for spinal cord injury and brain ... trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured ... injury (SCI). The Phase 1/2a trial ...
(Date:3/5/2015)... and VANCOUVER, British Columbia ... BUX FSE: 20B OTCQB: BMKDF) -- The ultimate goal ... assay that is capable of detecting tumors before they ... years, the development of such an assay has been ... academia and industry. Although many breakthrough diagnostics have been ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization, today ... on June 23, 2010 , at the InterContinental Hotel in Boston . ... Kendle,s formal presentation will be given by Chairman ... Time . , , , ...
... June 17 Brainlab AG today announced that it ... business unit of the Toshiba Group, to integrate its Aquilion™ LB ... operating room (OR). , , ... Stephan Holl , Chief Operating Officer, Brainlab, indicated that ...
Cached Medicine Technology:Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference 2Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite 2Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite 3
(Date:3/5/2015)... NY (PRWEB) March 05, 2015 Shania Twain ... in more than a decade. She has hinted that this ... to miss seeing her perform one last time. She has ... and this beloved country sweetheart has millions of loyal fans around ... throughout her native country, Canada, and on June 30th she will ...
(Date:3/5/2015)... 2015 This week, 60 ... low-cost laminate flooring products, initiating widespread concern from ... building materials made primarily from bamboo, stands behind ... their flooring products for volatile organic compounds (VOCs) ... International (BMH). Results from formaldehyde emissions testing ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned ... awarding the plaintiff Coleen M. Perry a total of $5.7 ... TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., a ... a partner at Wagstaff & Cartmell in Kansas ... along with Rich Freese and Tim Goss of Freese ...
(Date:3/5/2015)... 05, 2015 AxoGen, Inc. (NASDAQ: ... the peripheral nerve repair market, reported record revenue of ... 2014 compared to $2.98 million in the year-ago fourth ... strategies. , “Our strong fourth quarter revenue growth ... repair products which is driving increased surgeon adoption of ...
(Date:3/5/2015)... March 05, 2015 Risperdal lawsuits ... a Pennsylvania mass tort litigation currently underway in ... jury has begun hearing testimony in the proceeding’s ... antipsychotic medication can cause gynecomastia, or male breast ... question was filed on behalf of a plaintiff ...
Breaking Medicine News(10 mins):Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3
... CEO, Will Continue Serving as Chairman of the Board, ... Bulletin Board: MLSS), the recognized leader in,advanced injection technologies, ... Martin, Chief Executive Officer of the Company,s,medical division, as ... of its Board,of Directors, effective January 1, 2008. As ...
... Detection and treatment of tumours, diseased blood vessels and ... an innovative imaging system being developed that uses both ... extremely short pulses of low-energy laser light to stimulate ... area being examined. These waves are then converted into ...
... Amsterdam, December 12, 2007 Elsevier, a leading ... today announced that 45 French-language medical journals from ... January 3, 2008. , The titles, including Feuillets ... Mdicale, represent a wide range of high-quality journals ...
... by 81 percent of Michigan adults, DETROIT, Dec. ... of reform measures proposed in the Michigan Legislature,that would ... increases and set standard rating practices for all insurers ... made public today,by Blue Cross Blue Shield of Michigan., ...
... TITUSVILLE, N.J., Dec. 12 INVEGA(TM) (paliperidone),Extended-Release ... a one-year open-label extension (OLE) study, according ... symptom scores improved or,were stable, on average, ... was designed to evaluate the long-term safety ...
... it. Hair Fairies - The Head Lice, Helpers - is here to ... ... No two words in the English language,can stop every parent in ... other kid-centric services are often,sent into crisis mode when an outbreak occurs, ...
Cached Medicine News:Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 2Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 3Health News:Light and sound -- the way forward for better medical imaging 2Health News:ScienceDirect to host French-language journals from Elsevier Masson 2Health News:Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan 2Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 2Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 3Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 4Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 5Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 6Health News:Head Lice Removal Service Opens in Chicago 2Health News:Head Lice Removal Service Opens in Chicago 3
... fixed-volume, adjustable-volume, and multichannel models as ... pro Pipette. Designed with a separate ... have earned a worldwide reputation for ... original Eppendorf pipette tips, they provide ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Research Family includes fixed-volume, adjustable-volume, and ... electronic Eppendorf Research pro Pipette. Designed ... compact, high-performance pipettes have earned a ... for use with original Eppendorf pipette ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: